ChemicalBook >제품 카탈로그 >MDA 19

MDA 19

MDA 19 구조식 이미지

카스 번호:: 1048973-47-2

상품명:: MDA 19

동의어(영문):: MDA 19;MDA19; MDA-19;N'-(1-Hexyl-2-oxoindolin-3-ylidene)benzohydrazide;(Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide;N-[(Z)-(1-Hexyl-2-oxo-indolin-3-ylidene)aMino]benzaMide;N'-[(3Z)-1-Hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene]benzohydrazide;Benzoic acid (2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide;MDA 19 (Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide

CBNumber:: CB12535682

분자식:: C21H23N3O2

포뮬러 무게:: 349.43

MOL 파일:: 1048973-47-2.mol

속성

안전

용도

MDA 19 속성

밀도: 1.16±0.1 g/cm3 (20 ºC 760 Torr)

저장 조건: Store at -20°C

용해도: DMF: 20 mg/ml; DMSO: 10 mg/ml; Ethanol: 3 mg/ml; Methanol: 1 mg/ml

물리적 상태: 결정성 고체

산도 계수 (pKa): 10.45±0.20(Predicted)

색상: Light yellow to yellow

안전

MDA 19 C화학적 특성, 용도, 생산

용도

MDA 19 is a selective agonist of the human peripheral cannabinoid (CB2) receptor. A cell-based functional assay showed MDA is an inverse agonist of the CB2 receptor in rat. Acts as an inverse agonist at the rat CB2 receptor. Reported Ki values are 16.3 and 1130 nM for human CB2 and CB1 receptor respectively. MDA19 was effective in attenuating tactile allodynia in neuropathic rats. MDA19 thus has potential for alleviating neuropathic pain without producing adverse effects in the central nervous system.Synthetic Cannabinoids

MDA 19 준비 용품 및 원자재

원자재

준비 용품

MDA 19 관련 검색:

2-Nitro-4-methylsulfonylbenzoic acid 2,6-Dihydroxybenzoic acid 4-Methylsulphonylbenzoic acid 3,5-Dihydroxybenzoic acid